Literature DB >> 8803742

Number needed to treat is a simple measure of treatment efficacy for clinicians.

S V Rajkumar1, P Sampathkumar, A B Gustafson.   

Abstract

Mesh：

Year:  1996        PMID： 8803742     DOI： 10.1007/bf02600047

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  12 in total

1.  Absolutely relative: how research results are summarized can affect treatment decisions.

Authors:  L Forrow; W C Taylor; R M Arnold
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

2.  Inference and decision at the bedside.

Authors:  D L Sackett
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

3.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

4.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

5.  Thrombolytic agents: the science of the art of choosing the better treatment.

Authors:  M E Farkouh; J D Lang; D L Sackett
Journal:  Ann Intern Med       Date:  1994-05-15       Impact factor: 25.391

6.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

7.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

8.  Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

Authors:  I Nyman; H Larsson; L Wallentin
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

9.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

10.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Authors:  S Juul-Möller; N Edvardsson; B Jahnmatz; A Rosén; S Sørensen; R Omblus
Journal:  Lancet       Date:  1992-12-12       Impact factor: 79.321
View more
  2 in total

1.  A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats.

Authors:  Stacey L Sheridan; Michael P Pignone; Carmen L Lewis
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

2.  How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey.

Authors:  Francisco Acevedo; Cesar Sanchez; Jaime Jans; Solange Rivera; Mauricio Camus; Pelayo Besa
Journal:  Ecancermedicalscience       Date:  2014-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.